CStone Pharmaceuticals (HK:2616) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CStone Pharmaceuticals has announced the grant of 200,000 restricted share units (RSUs) and 6,280,000 share options to eligible employees as part of its post-IPO schemes. These grants are designed to align employee interests with company performance and market practices. The RSUs will vest over a four-year period with no performance targets attached.
For further insights into HK:2616 stock, check out TipRanks’ Stock Analysis page.